MeiraGTx Holdings PLC (FRA:328)
€ 6.1 -0.2 (-3.17%) Market Cap: 500.99 Mil Enterprise Value: 466.77 Mil PE Ratio: 0 PB Ratio: 5.50 GF Score: 47/100

MeiraGTx Holdings PLC at Bank of America Healthcare Conference Transcript

May 10, 2022 / 05:00PM GMT
Release Date Price: €8 (-8.57%)
Alec Warren Stranahan
BofA Securities, Research Division - Associate

Hey, everyone, good morning. Welcome to day 1 of the 2022 BofA Healthcare Conference, and thanks for joining the session with MeiraGTx. My name is Alec Stranahan. I'm Vice President and Senior Biotech analyst covering Meira here at BofA, and I'm pleased to be joined by Zandy Forbes, who's the President and Chief Executive Officer of Meira. I believe Zandy is going to run through some slides to start, and then we'll get into the Q&A. So with that, Zandy, over to you.

Alexandria Forbes
MeiraGTx Holdings plc - CEO, President & Director

Thank you, and thank you for inviting me to speak to this exclusive group. I hope that what I show you today will impress you enough to run away and tell your friends how amazing Meira is. So we are a gene therapy company and very unusual because of the way we were set up. We started in 2015, not to focus on a particular indication, but rather on the capabilities that are required for any gene therapy company to have a clinical pipeline and commercialize

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot